This article's factual accuracy may be compromised due to out-of-date information. Please help update this article to reflect recent events or newly available information. (August 2013)

Annual Sales (USD Millions)

Medication Trade name Primary Indication Company 2015 2014 2013 2012 2011 2010 2009 2008[1][2][3][4][5][6] 2007[7][8][9][10][11][12] 2006[13][14][15][16][17][18] 2005[19][20][21][22][23] 2004[24][25][26][27] 2003[28][29][30][31] 2002[32][33][34][35] 2001[36] 2000[37][38]
atorvastatin Lipitor Reduction of LDL cholesterol Pfizer $12,401 $12,675 $12,886 $12,187 $10,862 $9,231 $7,972 $6,448 $5,028
sunitinib malate Sutent Advanced and/or metastatic renal cell carcinoma (mRCC) & refractory gastrointestinal stromal tumors (GIST) Pfizer $847 $581 $219
irinotecan Camptosar Metastatic colorectal cancer Pfizer $563 $969 $903 $910 $554 $299
bimatoprost Lumigan Open-angle glaucoma or ocular hypertension Allergan $426.2 $391.7 $327.5 $267.6 $232.9 $181.3 $123 $35.4
exemestane Aromasin Breast cancer Pfizer $465 $401 $320 $247 $143 $58
epirubicin Ellence Breast cancer Pfizer $312 $367 $344 $216
trastuzumab Herceptin HER2-positive metastatic breast cancer Genentech $1,382 $1,287 $1,234 $747.2 $483.2 $424.8 $385.2 $346.7 $276
gemcitabine Gemzar Ovarian cancer, non-small cell lung cancer (NSCLC), metastatic breast cancer (MBC), and pancreatic cancer Eli Lilly & Co. $1,719.8 $1,592.4 $1,408.1 $1,334.5 $1,214.4 $1,021.7 $875 $723 $559.3
bevacizumab Avastin Metastatic colorectal cancer, non-small cell lung cancer (NSCLC), renal cell carcinoma, HER2-negative breast cancer Genentech $2,686 $2,296 $1,746 $1,132 $554.6
erlotinib Tarceva Advanced (metastatic) non-small cell lung cancer (NSCLC) Genentech $457 $417 $402 $274.9 $13.3
brimonidine Alphagan Open-angle glaucoma or ocular hypertension Allergan $286.8 $248.5 $250.9
rituximab Rituxan Non-Hodgkin's lymphoma and rheumatoid arthritis Genentech $2,587 $2,285 $2,071 $1,831.4 $1,574 $1,360.2 $1,162.9 $818.6
ranibizumab Lucentis Age-related macular degeneration (AMD) Genentech $875 $815 $380
omalizumab Xolair Asthma Genentech $517 $472 $425 $320.6 $187.6 $25.1
somatropin Nutropin Growth hormone deficiency, chronic kidney disease Genentech $358 $371 $378 $370.5 $348.8 $319.5
dornase alfa Pulmozyme Cystic fibrosis (CF) Genentech $257 $223 $199 $186.5 $157.1 $143.7 $138.1 $123
efalizumab Raptiva Plaque psoriasis Genentech $108 $107 $90 $79.2 $52.4 $1.4
montelukast Singulair Asthma Merck $4,336.9 $4,266.3 $3,579 $2,975.6 $2,622
alendronate sodium Fosamax Postmenopausal osteoporosis Merck $1,552.7 $3,049 $3,134.4 $3,191.2 $3,159.7
sitagliptin Januvia Type 2 diabetes Merck $1,397.1 $667.5 $42.9
simvastatin Zocor Reduction of LDL cholesterol Merck $660.1 $876.5 $2,802.7 $4,381.7 $5,196.5
rizatriptan benzoate Maxalt Migraine pain Merck $529.2 $467.3 $406.4 $348.4 $309.9
finasteride Propecia Hair loss Merck $429.1 $405.4 $351.8 $291.9 $270.2
etoricoxib Arcoxia Osteoarthritis and rheumatoid arthritis Merck $377.3 $329.1 $265.4 $218.2
sitagliptin/metformin HCl Janumet Type 2 diabetes Merck $351.1 $86.4
finasteride Proscar Benign prostatic hyperplasia (enlarged prostate) Merck $323.5 $411 $618.5 $741.4 $733.1
aprepitant Emend Nausea and vomiting prevention caused by chemotherapy Merck $263.8 $204.2 $130.8 $87
olanzapine Zyprexa Schizophrenia Eli Lilly & Co. $4,696.1 $4,761 $4,363.6 $4,202.3 $4,419.8 $4,276.9 $3,689 $3,087 $2,349.5
duloxetine HCl Cymbalta Depression and generalized anxiety disorder Eli Lilly & Co. $2,697.1 $2,102.9 $1,316.4 $679.7 $93.9
insulin lispro Humalog Type 1 diabetes in adults Eli Lilly & Co. $1,735.8 $1,474.6 $1,299.5 $1,197.7 $1,101.6 $1,021.3 $834 $628 $350.2
pemetrexed Alimta Locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) Eli Lilly & Co. $1,154.7 $854 $611.8 $463.2 $142.6
raloxifene HCl Evista Osteoporosis Eli Lilly & Co. $1,075.6 $1,090.7 $1,045.3 $1,036.1 $1,012.7 $922.1 $822 $665 $521.5
insulin isophane Humulin Diabetes Eli Lilly & Co. $1,063.2 $985.2 $925.3 $1,004.7 $997.7 $1,060.4 $1,004 $1,061 $1,114.5
teriparatide Forteo Osteoporosis Eli Lilly & Co. $778.7 $709.3 $594.3 $389.3 $238.6 $65.3
atomoxetine HCl Strattera Attention-deficit/hyperactivity disorder (ADHD) Eli Lilly & Co. $579.5 $569.4 $579 $552.1 $666.7 $370.3
timolol Istalol Open-angle glaucoma Ista Pharmaceutical $14.6 $11.3 $8.3 $2.6
bromfenac Xibrom Ocular inflammation Ista Pharmaceutical $63 $42.1 $20.2 $5.3
hyaluronidase Vitrase Spreading agent Ista Pharmaceutica $5.2 $5.2 $4.2 $2.5
rivaroxaban Xarelto Deep vein thrombosis Johnson & Johnson[39] $1,868 $1,522 $864 $239 $25

Notes

  1. ^ [1], Genentech 2008 10-K.
  2. ^ [2], Pfizer 2008 10-K.
  3. ^ [3], Eli Lilly & Co. 2008 10-K.
  4. ^ [4], Allergan 2008 10-K.
  5. ^ [5], Merck 2008 10-K.
  6. ^ [6], Ista Pharmaceuticals 2008 10-K.
  7. ^ [7], Genentech 2007 10-K.
  8. ^ [8], Pfizer 2007 10-K.
  9. ^ [9], Eli Lilly & Co. 2007 10-K.
  10. ^ [10], Allergan 2007 10-K.
  11. ^ [11], Merck 2007 10-K.
  12. ^ [12], Ista Pharmaceuticals 2007 10-K.
  13. ^ [13], Genentech 2006 10-K.
  14. ^ [14], Pfizer 2006 10-K.
  15. ^ [15], Eli Lilly & Co. 2006 10-K.
  16. ^ [16], Allergan 2006 10-K.
  17. ^ [17], Merck 2006 10-K.
  18. ^ [18], Ista Pharmaceuticals 2006 10-K.
  19. ^ [19], Genentech 2005 10-K.
  20. ^ [20], Pfizer 2005 10-K.
  21. ^ [21], Eli Lilly & Co. 2005 10-K.
  22. ^ [22], Allergan 2005 10-K.
  23. ^ [23], Merck 2005 10-K.
  24. ^ [24], Genentech 2004 10-K.
  25. ^ [25], Pfizer 2004 10-K.
  26. ^ [26], Eli Lilly & Co. 2004 10-K.
  27. ^ [27], Allergan 2004 10-K.
  28. ^ [28], Genentech 2003 10-K.
  29. ^ [29], Pfizer 2003 10-K.
  30. ^ [30], Eli Lilly & Co. 2003 10-K.
  31. ^ [31], Allergan 2003 10-K.
  32. ^ [32], Genentech 2002 10-K.
  33. ^ [33], Pfizer 2002 10-K.
  34. ^ [34], Eli Lilly & Co. 2002 10-K.
  35. ^ [35], Allergan 2002 10-K.
  36. ^ [36], Pfizer 2001 10-K.
  37. ^ [37], Genentech 2000 10-K.
  38. ^ [38], Eli Lilly & Co. 2000 10-K.
  39. ^ "SEC Filings - Johnson & Johnson". www.investor.jnj.com. Archived from the original on 2016-04-09. Retrieved 2016-03-25.
Categories